Marker Therapeutics, Inc. earnings per share and revenue

MRKR earnings per share for the last quarter are -0.26 USD whereas the estimation was -0.39 USD which accounts for 33.33% surprise. Company revenue for the same period amounts to 1.93 M USD despite the estimated figure of 1.00 M USD. Estimated earnings per share for the next quarter are -0.28 USD, and revenue is expected to reach 1.00 M USD. Also watch annual changes over time to get a bigger picture of MRKR earnings per share and revenue dynamics.